Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT TEMOZOLOMIDE 20MG CAPSULE Resolved 2020-01-30 2020-07-09 104922
ACT TERBINAFINE 250MG TABLET Resolved 2020-07-23 2020-09-24 120905
ACT TERBINAFINE 250MG TABLET Resolved 2023-06-19 2023-08-17 195629
ACT TERBINAFINE 250MG TABLET Resolved 2025-01-30 2025-01-30 249182
ACT TERBINAFINE 250MG TABLET Resolved 2020-04-10 2023-10-03 111874
ACT TERBINAFINE 250MG TABLET Resolved 2024-10-11 2025-09-02 240028
ACT TERBINAFINE 250MG TABLET Resolved 2023-02-09 2023-07-05 184195
ACT TERBINAFINE 250MG TABLET Resolved 2024-10-11 2025-09-02 240037
AERMONY RESPICLICK 232MCG POWDER (METERED DOSE) Resolved 2022-12-01 2023-04-28 176860
AERMONY RESPICLICK 55MCG POWDER (METERED DOSE) Resolved 2022-12-01 2023-01-18 176791
ALERTEC 100MG TABLET Resolved 2022-08-18 2022-09-23 167165
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2020-11-06 2021-03-18 128031
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2021-10-28 2021-11-25 148421
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-06-03 2021-08-05 140369
AMPICILLIN SODIUM FOR INJECTION, USP 1000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86939
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2025-04-04 2025-10-10 254136
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Actual shortage 2025-06-19 2025-12-18 260642
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2025-06-05 2025-12-11 259685
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2021-08-13 2021-10-07 144105
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-VALSARTAN 80MG TABLET Discontinued 2025-04-29 2025-04-29 256149
TEVA-VALSARTAN/HCTZ 25MG 160MG TABLET Discontinued 2025-04-25 2025-04-25 255833
TEVA-VALSARTAN/HCTZ 12.5MG 320MG TABLET Discontinued 2025-04-29 2025-04-29 256140
TEVA-VALSARTAN/HCTZ 25MG 320MG TABLET Discontinued 2025-04-29 2025-04-29 256143
TEVA-VALSARTAN/HCTZ 12.5MG 160MG TABLET Discontinued 2025-04-25 2025-04-25 255830
TEVA-VALSARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2025-04-25 2025-04-25 255827
TEVA-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-02-07 2020-02-08 105537
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-09-24 2020-09-24 124899
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-06-11 2020-06-11 117546
TEVA-VORICONAZOLE 50MG TABLET Discontinued 2025-04-29 2025-04-29 256169
TEVA-VORICONAZOLE 200MG TABLET Discontinued 2025-04-29 2025-04-29 256166
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Discontinued 2019-10-17 2019-10-17 96695
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Discontinued 2019-09-27 2019-10-01 94980
ZOLEDRONIC ACID FOR INJECTION 4MG SOLUTION Discontinued 2025-05-28 2025-05-28 258583
ZOLEDRONIC ACID INJECTION 5MG SOLUTION Discontinued 2017-06-27 2017-06-27 14030

Showing 421 to 435 of 435